Digital Biomarkers: Global Markets
Report Scope:
The current report highlights the current and future market potential of digital biomarkers and also covers market projections to 2026, along with rankings for key market players. It also analyzes the competitive landscape and the regulatory scenario. The report determines the market share of digital biomarkers based on system components, application, therapeutic area and end user. The market by system component is segmented into data collection tools and data integration tools; by application, it is segmented into diagnostic digital biomarkers, monitoring digital biomarkers, predictive digital biomarkers and others; by therapeutic area, it is categorized into cardiovascular and metabolic disorders (CVMD), psychiatric disorders, neurological disorders, respiratory disorders, musculoskeletal disorders and others; and by end user, it is segmented into pharmaceutical companies and research institutions, healthcare providers, payers, employers, patients and caregivers. The report also assesses the impact of the COVID-19 pandemic on this market.
By geography, the market has been segmented into North America, Europe, Asia-Pacific and the rest of the world (RoW). North America consists of the U.S., Canada and Mexico; Europe includes Germany, the U.K., Belgium and Rest of Europe; and Asia-Pacific includes China, Australia, Japan and Rest of Asia-Pacific. For market estimates, data has been provided for the 2019 as the historic year, 2020 as the base year and forecast for 2026.
Report Includes:
The current report highlights the current and future market potential of digital biomarkers and also covers market projections to 2026, along with rankings for key market players. It also analyzes the competitive landscape and the regulatory scenario. The report determines the market share of digital biomarkers based on system components, application, therapeutic area and end user. The market by system component is segmented into data collection tools and data integration tools; by application, it is segmented into diagnostic digital biomarkers, monitoring digital biomarkers, predictive digital biomarkers and others; by therapeutic area, it is categorized into cardiovascular and metabolic disorders (CVMD), psychiatric disorders, neurological disorders, respiratory disorders, musculoskeletal disorders and others; and by end user, it is segmented into pharmaceutical companies and research institutions, healthcare providers, payers, employers, patients and caregivers. The report also assesses the impact of the COVID-19 pandemic on this market.
By geography, the market has been segmented into North America, Europe, Asia-Pacific and the rest of the world (RoW). North America consists of the U.S., Canada and Mexico; Europe includes Germany, the U.K., Belgium and Rest of Europe; and Asia-Pacific includes China, Australia, Japan and Rest of Asia-Pacific. For market estimates, data has been provided for the 2019 as the historic year, 2020 as the base year and forecast for 2026.
Report Includes:
- 56 tables
- An overview of the global markets for digital biomarkers
- Estimation of the market size and analyses of market trends, with data from 2019, 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
- Information on major market drivers, opportunities and challenges, industry chain structure, distribution channel, and technological advancements that are affecting the overall marketplace
- Assessment of market potential and revenue forecast for digital biomarkers market based on system component, application, therapeutic area, end user and region
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Company profiles of the leading market players including AliveCor, Biogen Inc., Embic Corp., Fitbit, Happify Health, Mindstrong Health, and Winterlight Labs
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing this Study
Scope of this Report
Methodology
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Highlights
CHAPTER 3 DIGITAL BIOMARKERS: BACKGROUND AND TECHNOLOGY
Digital Biomarkers Overview
CHAPTER 4 MARKET DYNAMICS
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
CHAPTER 5 MARKET BREAKDOWN BY SYSTEM COMPONENT
Global Market for Digital Biomarkers
Market Analysis
Data Collection Tools
Data Integration Tools
CHAPTER 6 MARKET BREAKDOWN BY APPLICATION
Diagnostic Digital Biomarkers
Monitoring Digital Biomarkers
Predictive Digital Biomarkers
Other Digital Biomarkers
CHAPTER 7 MARKET BREAKDOWN BY THERAPEUTIC AREA
Global Market for Digital Biomarkers by Therapeutic Area
CVMD
Psychiatric Disorders
Neurology
Respiratory Disorders
Musculoskeletal
Other Therapeutic Areas
CHAPTER 8 MARKET BREAKDOWN BY END USER
Global Market for Digital Biomarkers by End User
Pharmaceutical Companies and Research Institutions
Healthcare Providers
Payers
Employers
Patients and Caregivers
CHAPTER 9 MARKET BREAKDOWN BY REGION
Global Market for Digital Biomarkers by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 10 REGULATORY SCENARIO
U.S.
Canada
Europe
Asia-Pacific
CHAPTER 11 IMPACT OF THE COVID-19 PANDEMIC
COVID-19’s Impact on the Digital Biomarker Market
CHAPTER 12 COMPETITIVE LANDSCAPE
Overview
Pharmaceutical Companies
Large Technology Companies
Small-Medium Sized Technology Companies
Recent Developments of Key Companies
Other Notable Partnerships and Funding Activities
CHAPTER 13 COMPANY PROFILES
ACTIGRAPH LLC
ALIVECOR INC.
AKILI INTERACTIVE LABS INC.
BIOGEN INC.
EMBIC CORP.
EVIDATION HEALTH INC.
FITBIT LLC
HAPPIFY HEALTH
HUMA
IXICO PLC
KONEKSA
MINDSTRONG HEALTH
WINTERLIGHT LABS
CHAPTER 14 APPENDIX: LIST OF ACRONYMS
Study Goals and Objectives
Reasons for Doing this Study
Scope of this Report
Methodology
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Highlights
CHAPTER 3 DIGITAL BIOMARKERS: BACKGROUND AND TECHNOLOGY
Digital Biomarkers Overview
CHAPTER 4 MARKET DYNAMICS
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
CHAPTER 5 MARKET BREAKDOWN BY SYSTEM COMPONENT
Global Market for Digital Biomarkers
Market Analysis
Data Collection Tools
Data Integration Tools
CHAPTER 6 MARKET BREAKDOWN BY APPLICATION
Diagnostic Digital Biomarkers
Monitoring Digital Biomarkers
Predictive Digital Biomarkers
Other Digital Biomarkers
CHAPTER 7 MARKET BREAKDOWN BY THERAPEUTIC AREA
Global Market for Digital Biomarkers by Therapeutic Area
CVMD
Psychiatric Disorders
Neurology
Respiratory Disorders
Musculoskeletal
Other Therapeutic Areas
CHAPTER 8 MARKET BREAKDOWN BY END USER
Global Market for Digital Biomarkers by End User
Pharmaceutical Companies and Research Institutions
Healthcare Providers
Payers
Employers
Patients and Caregivers
CHAPTER 9 MARKET BREAKDOWN BY REGION
Global Market for Digital Biomarkers by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 10 REGULATORY SCENARIO
U.S.
Canada
Europe
Asia-Pacific
CHAPTER 11 IMPACT OF THE COVID-19 PANDEMIC
COVID-19’s Impact on the Digital Biomarker Market
CHAPTER 12 COMPETITIVE LANDSCAPE
Overview
Pharmaceutical Companies
Large Technology Companies
Small-Medium Sized Technology Companies
Recent Developments of Key Companies
Other Notable Partnerships and Funding Activities
CHAPTER 13 COMPANY PROFILES
ACTIGRAPH LLC
ALIVECOR INC.
AKILI INTERACTIVE LABS INC.
BIOGEN INC.
EMBIC CORP.
EVIDATION HEALTH INC.
FITBIT LLC
HAPPIFY HEALTH
HUMA
IXICO PLC
KONEKSA
MINDSTRONG HEALTH
WINTERLIGHT LABS
CHAPTER 14 APPENDIX: LIST OF ACRONYMS
LIST OF TABLES
Summary Table: Global Market for Digital Biomarkers, by System Component, Through 2026
Table 1: Types of Digital Biomarkers
Table 2: Comparison of Traditional and Digital Biomarkers
Table 3: Digital Health Apps Globally, 2015-2021
Table 4: Technology Innovations by Digital Biomarker Companies
Table 5: Key Research Collaborations and Partnerships
Table 6: Global Market for Digital Biomarkers, by System Component, Through 2026
Table 7: Global Market for Data Collection Tools, by Region, Through 2026
Table 8: Global Market for Data Collection Tools, by Type, Through 2026
Table 9: Global Market for Mobile and Web Apps as Data Collection Tools, Through 2026
Table 10: Global Market for Wearable Data Collection Tools, by Region, Through 2026
Table 11: Global Market for Implantable and Ingestible Data Collection Tools, by Region, Through 2026
Table 12: Global Market for Other Data Collection Tools, by Region, Through 2026
Table 13: Global Market for Data Integration Tools, by Region, Through 2026
Table 14: Global Market for Digital Biomarkers, by Application, Through 2026
Table 15: Global Market for Diagnostic Digital Biomarkers, by Region, Through 2026
Table 16: Global Market for Monitoring Digital Biomarkers, by Region, Through 2026
Table 17: Global Market for Predictive Digital Biomarkers, by Region, Through 2026
Table 18: Global Market for Other Digital Biomarkers, by Region, Through 2026
Table 19: Global Market for Digital Biomarkers, by Therapeutic Area, Through 2026
Table 20: Global Market for Digital Biomarkers for CVMD, by Region, Through 2026
Table 21: Global Market for Digital Biomarkers for Psychiatric Disorders, by Region, Through 2026
Table 22: Global Market for Digital Biomarkers for Neurology, by Region, Through 2026
Table 23: Global Market for Digital Biomarkers for Respiratory Disorders, by Region, Through 2026
Table 24: Global Market for Digital Biomarkers for Musculoskeletal, by Region, Through 2026
Table 25: Global Market for Digital Biomarkers for Other Therapeutic Areas, by Region, Through 2026
Table 26: Global Market for Digital Biomarkers, by End User, Through 2026
Table 27: Global Market for Digital Biomarkers, by Region, Through 2026
Table 28: North American Market for Digital Biomarkers, by Country, Through 2026
Table 29: European Market for Digital Biomarkers, by Country, Through 2026
Table 30: Asia-Pacific Market for Digital Biomarkers, by Country, Through 2026
Table 31: Collaborations Between Pharmaceutical and Digital Biomarker Companies, 2021-2022
Table 32: Actigraph LLC: Product Portfolio
Table 33: Actigraph LLC: Key Developments
Table 34: AliveCor: Product Portfolio
Table 35: AliveCor: Key Developments
Table 36: Akili Interactive Labs: Product Portfolio
Table 37: Akili Interactive Labs: Key Developments
Table 38: Biogen Product Portfolio
Table 39: Embic: Product Portfolio
Table 40: Evidation Health: Product Portfolio
Table 41: Evidation Health: Key Developments
Table 42: Fitbit: Product Portfolio
Table 43: Fitbit: Key Developments
Table 44: Happify Health: Product Portfolio
Table 45: Happify Health: Key Developments
Table 46: Huma: Product Portfolio
Table 47: Ixico: Product Portfolio
Table 48: Ixico: Key Developments
Table 49: Koneksa Product Portfolio
Table 50: Koneska: Key Developments
Table 51: Mindstrong Health: Product Portfolio
Table 52: Mindstrong Health: Key Developments
Table 53: Winterlight Labs: Product Portfolio
Table 54: Winterlight Labs: Key Developments
Table 55: Acronyms Used in This Report
Summary Table: Global Market for Digital Biomarkers, by System Component, Through 2026
Table 1: Types of Digital Biomarkers
Table 2: Comparison of Traditional and Digital Biomarkers
Table 3: Digital Health Apps Globally, 2015-2021
Table 4: Technology Innovations by Digital Biomarker Companies
Table 5: Key Research Collaborations and Partnerships
Table 6: Global Market for Digital Biomarkers, by System Component, Through 2026
Table 7: Global Market for Data Collection Tools, by Region, Through 2026
Table 8: Global Market for Data Collection Tools, by Type, Through 2026
Table 9: Global Market for Mobile and Web Apps as Data Collection Tools, Through 2026
Table 10: Global Market for Wearable Data Collection Tools, by Region, Through 2026
Table 11: Global Market for Implantable and Ingestible Data Collection Tools, by Region, Through 2026
Table 12: Global Market for Other Data Collection Tools, by Region, Through 2026
Table 13: Global Market for Data Integration Tools, by Region, Through 2026
Table 14: Global Market for Digital Biomarkers, by Application, Through 2026
Table 15: Global Market for Diagnostic Digital Biomarkers, by Region, Through 2026
Table 16: Global Market for Monitoring Digital Biomarkers, by Region, Through 2026
Table 17: Global Market for Predictive Digital Biomarkers, by Region, Through 2026
Table 18: Global Market for Other Digital Biomarkers, by Region, Through 2026
Table 19: Global Market for Digital Biomarkers, by Therapeutic Area, Through 2026
Table 20: Global Market for Digital Biomarkers for CVMD, by Region, Through 2026
Table 21: Global Market for Digital Biomarkers for Psychiatric Disorders, by Region, Through 2026
Table 22: Global Market for Digital Biomarkers for Neurology, by Region, Through 2026
Table 23: Global Market for Digital Biomarkers for Respiratory Disorders, by Region, Through 2026
Table 24: Global Market for Digital Biomarkers for Musculoskeletal, by Region, Through 2026
Table 25: Global Market for Digital Biomarkers for Other Therapeutic Areas, by Region, Through 2026
Table 26: Global Market for Digital Biomarkers, by End User, Through 2026
Table 27: Global Market for Digital Biomarkers, by Region, Through 2026
Table 28: North American Market for Digital Biomarkers, by Country, Through 2026
Table 29: European Market for Digital Biomarkers, by Country, Through 2026
Table 30: Asia-Pacific Market for Digital Biomarkers, by Country, Through 2026
Table 31: Collaborations Between Pharmaceutical and Digital Biomarker Companies, 2021-2022
Table 32: Actigraph LLC: Product Portfolio
Table 33: Actigraph LLC: Key Developments
Table 34: AliveCor: Product Portfolio
Table 35: AliveCor: Key Developments
Table 36: Akili Interactive Labs: Product Portfolio
Table 37: Akili Interactive Labs: Key Developments
Table 38: Biogen Product Portfolio
Table 39: Embic: Product Portfolio
Table 40: Evidation Health: Product Portfolio
Table 41: Evidation Health: Key Developments
Table 42: Fitbit: Product Portfolio
Table 43: Fitbit: Key Developments
Table 44: Happify Health: Product Portfolio
Table 45: Happify Health: Key Developments
Table 46: Huma: Product Portfolio
Table 47: Ixico: Product Portfolio
Table 48: Ixico: Key Developments
Table 49: Koneksa Product Portfolio
Table 50: Koneska: Key Developments
Table 51: Mindstrong Health: Product Portfolio
Table 52: Mindstrong Health: Key Developments
Table 53: Winterlight Labs: Product Portfolio
Table 54: Winterlight Labs: Key Developments
Table 55: Acronyms Used in This Report
LIST OF FIGURES
Summary Figure: Global Market for Digital Biomarkers, by System Component, 2019-2026
Figure 1: Distribution of Clinical Trials with Digital Biomarkers as Endpoints by Therapeutic Area
Figure 2: Global Shares of Digital Biomarker System Components, 2020
Figure 3: Global Market for Data Collection Tools, by Region, 2019-2026
Figure 4: Global Market Shares of Digital Biomarker Data Collection Tools, 2020
Figure 5: Global Market for Data Integration Tools, by Region, 2019-2026
Figure 6: Global Market Shares of Digital Biomarkers, by Application, 2020
Figure 7: Global Market for Diagnostic Digital Biomarkers, 2019-2026
Figure 8: Global Market for Monitoring Digital Biomarkers, 2019-2026
Figure 9: Global Market for Predictive Digital Biomarkers, 2019-2026
Figure 10: Global Market for Other Digital Biomarkers, 2019-2026
Figure 11: Global Market Shares of Digital Biomarkers, by Therapeutic Area, 2020
Figure 12: Global Market Shares of Digital Biomarkers, by End User, 2020
Figure 13: Global Market for Digital Biomarkers, by End User, 2019-2026
Figure 14: Global Market for Digital Biomarkers Used by Pharmaceutical Companies and Research Institutions, 2019-2026
Figure 15: Global Market for Digital Biomarkers Used by Healthcare Providers, 2019-2026
Figure 16: Global Market for Digital Biomarkers Used by Payers, 2019-2026
Figure 17: Global Market for Digital Biomarkers Used by Employers, 2019-2026
Figure 18: Global Market for Digital Biomarkers Used by Patients and Caregivers, 2019-2026
Figure 19: Global Market Shares of Digital Biomarkers, by Region, 2020
Figure 20: North American Market Shares of Digital Biomarkers, by Country, 2020
Figure 21: U.S. Market for Digital Biomarkers, 2019-2026
Figure 22: Canadian Market for Digital Biomarkers, 2019-2026
Figure 23: Mexican Market for Digital Biomarkers, 2019-2026
Figure 24: European Market Shares of Digital Biomarkers, by Country, 2020
Figure 25: German Market for Digital Biomarkers, 2019-2026
Figure 26: U.K. Market for Digital Biomarkers, 2019-2026
Figure 27: Belgian Market for Digital Biomarkers, 2019-2026
Figure 28: Rest of Europe Market for Digital Biomarkers, 2019-2026
Figure 29: Asia-Pacific Market Shares of Digital Biomarkers, by Country, 2020
Figure 30: Chinese Market for Digital Biomarkers, 2019-2026
Figure 31: Australian Market for Digital Biomarkers, 2019-2026
Figure 32: Japanese Market for Digital Biomarkers, 2019-2026
Figure 33: Rest of Asia-Pacific Market for Digital Biomarkers, 2019-2026
Figure 34: RoW Market for Digital Biomarkers, 2019-2026
Figure 35: Digital Biomarkers: Competitor Types and Their Strategies
Figure 36: Biogen: Annual Revenue, 2018-2020
Figure 37: Biogen: Revenue Share, by Region, 2020
Figure 38: Fitbit: Annual Revenue, 2019 and 2020
Figure 39: Ixico: Annual Revenue, 2019 and 2020
Summary Figure: Global Market for Digital Biomarkers, by System Component, 2019-2026
Figure 1: Distribution of Clinical Trials with Digital Biomarkers as Endpoints by Therapeutic Area
Figure 2: Global Shares of Digital Biomarker System Components, 2020
Figure 3: Global Market for Data Collection Tools, by Region, 2019-2026
Figure 4: Global Market Shares of Digital Biomarker Data Collection Tools, 2020
Figure 5: Global Market for Data Integration Tools, by Region, 2019-2026
Figure 6: Global Market Shares of Digital Biomarkers, by Application, 2020
Figure 7: Global Market for Diagnostic Digital Biomarkers, 2019-2026
Figure 8: Global Market for Monitoring Digital Biomarkers, 2019-2026
Figure 9: Global Market for Predictive Digital Biomarkers, 2019-2026
Figure 10: Global Market for Other Digital Biomarkers, 2019-2026
Figure 11: Global Market Shares of Digital Biomarkers, by Therapeutic Area, 2020
Figure 12: Global Market Shares of Digital Biomarkers, by End User, 2020
Figure 13: Global Market for Digital Biomarkers, by End User, 2019-2026
Figure 14: Global Market for Digital Biomarkers Used by Pharmaceutical Companies and Research Institutions, 2019-2026
Figure 15: Global Market for Digital Biomarkers Used by Healthcare Providers, 2019-2026
Figure 16: Global Market for Digital Biomarkers Used by Payers, 2019-2026
Figure 17: Global Market for Digital Biomarkers Used by Employers, 2019-2026
Figure 18: Global Market for Digital Biomarkers Used by Patients and Caregivers, 2019-2026
Figure 19: Global Market Shares of Digital Biomarkers, by Region, 2020
Figure 20: North American Market Shares of Digital Biomarkers, by Country, 2020
Figure 21: U.S. Market for Digital Biomarkers, 2019-2026
Figure 22: Canadian Market for Digital Biomarkers, 2019-2026
Figure 23: Mexican Market for Digital Biomarkers, 2019-2026
Figure 24: European Market Shares of Digital Biomarkers, by Country, 2020
Figure 25: German Market for Digital Biomarkers, 2019-2026
Figure 26: U.K. Market for Digital Biomarkers, 2019-2026
Figure 27: Belgian Market for Digital Biomarkers, 2019-2026
Figure 28: Rest of Europe Market for Digital Biomarkers, 2019-2026
Figure 29: Asia-Pacific Market Shares of Digital Biomarkers, by Country, 2020
Figure 30: Chinese Market for Digital Biomarkers, 2019-2026
Figure 31: Australian Market for Digital Biomarkers, 2019-2026
Figure 32: Japanese Market for Digital Biomarkers, 2019-2026
Figure 33: Rest of Asia-Pacific Market for Digital Biomarkers, 2019-2026
Figure 34: RoW Market for Digital Biomarkers, 2019-2026
Figure 35: Digital Biomarkers: Competitor Types and Their Strategies
Figure 36: Biogen: Annual Revenue, 2018-2020
Figure 37: Biogen: Revenue Share, by Region, 2020
Figure 38: Fitbit: Annual Revenue, 2019 and 2020
Figure 39: Ixico: Annual Revenue, 2019 and 2020
